Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Ventria Bioscience logo — company profile

Ventria Bioscience

Founded 1993 Grant Total: $7.67M Biotechnology, Health Care +2

General Information

Company Name Ventria Bioscience
Founded Year 1993
Industries Biotechnology, Health Care, Manufacturing +1
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Ventria Bioscience. To contact Ventria Bioscience, visit ventria.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Ventria Bioscience compare?

A PDF of Ventria Bioscience and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Ventria Bioscience soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Ventria Bioscience

Ventria Bioscience is a biopharmaceutical company established in 1993. They utilize their proprietary ExpressTec technology to achieve significantly higher yields of recombinant protein production compared to other plant-based systems. This patented plant-based manufacturing method, ExpressTec, enables the company to explore new product opportunities that were previously unattainable. The platform technology supports the development of biotherapeutics, innovative vaccines, biomanufacturing reagents, and industrial and biofuel enzymes, providing substantial and sustainable economic benefits. They recently received a $4.20M grant investment on 23 October 2017 from the Bill & Melinda Gates Foundation. This investment will likely support Ventria Bioscience in further developing their innovative products and expanding their influence within the biotechnology, healthcare, manufacturing, and pharmaceutical industries. With their groundbreaking technology and recent investment, Ventria Bioscience presents an intriguing opportunity for venture capital firms looking to invest in the future of biopharmaceutical innovation.

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $4.20M 1
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation
23 Oct 2017
Venture Round $3.47M -
31 Dec 2010

FAQ About Ventria Bioscience

Ventria Bioscience is a privately held biopharmaceutical company that leverages its proprietary ExpressTec technology to achieve significantly higher yields of recombinant protein production compared to other plant-based systems. ExpressTec, a patented plant-based manufacturing method, enables the c...
Ventria Bioscience was founded in 1993.
Ventria Bioscience operates in Biotechnology, Health Care, Manufacturing and Pharmaceutical.
Ventria Bioscience has completed 2 funding rounds, raising a total of $7.67M. The latest funding stage is Grant.

We're actively collecting intelligence on Ventria Bioscience.

Source: BounceWatch company record for Ventria Bioscience, https://bouncewatch.com/company/ventria-bioscience, updated 9 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes